SCHEMBL7119231

SCHEMBL7119231

CC(N)Oc1ccccc1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
TDP1 Q9NUW8 3/20 0.59
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
RECQL P46063 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HPGD P15428 1/20 0.49
KMT2A Q03164 6/20 0.47
MEN1 O00255 4/20 0.47
LMNA P02545 3/20 0.47
MAPT P10636 3/20 0.47
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7902379 0.91 ALDH1A1 (0.50) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL27952716 0.85 ALDH1A1 (0.63) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL1342303 0.85 ALDH1A1 (0.63) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL3043522 0.82 ALDH1A1 (0.59) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL27829640 0.82 ALDH1A1 (0.59) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL10666114 0.82 ALDH1A1 (0.59) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL10583683 0.82 ALDH1A1 (0.65) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL14476702 0.81 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL14460830 0.81 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL8477414 0.81 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026666-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed